{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T01:17:25Z","timestamp":1789521445013,"version":"build-2803163510"},"reference-count":58,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["CHEST"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.chest.2026.05.032","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T08:07:18Z","timestamp":1780474038000},"page":"796-805","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Calcium and Vitamin D Supplements in Patients With Sarcoidosis"],"prefix":"10.1016","volume":"170","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4817-9404","authenticated-orcid":false,"given":"Patompong","family":"Ungprasert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah F.","family":"Keller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A.","family":"Culver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.chest.2026.05.032_bib1","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.mayocp.2015.10.024","article-title":"Epidemiology of sarcoidosis 1946-2013: a population-based study","volume":"91","author":"Ungprasert","year":"2016","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"10.1016\/j.chest.2026.05.032_bib2","first-page":"119","article-title":"The clinical course of sarcoidosis: presentation, diagnosis, and treatment in a large white and black cohort in the United States, Sarcoidosis Vasc Diff Lung","volume":"29","author":"Judson","year":"2012","journal-title":"Dis"},{"issue":"10 pt 1","key":"10.1016\/j.chest.2026.05.032_bib3","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1164\/ajrccm.164.10.2104046","article-title":"Clinical characteristics of patients in a case control study of sarcoidosis","volume":"164","author":"Baughman","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.chest.2026.05.032_bib4","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1097\/00063198-200009000-00010","article-title":"Hypercalcemia in granulomatous disorders: a clinical review","volume":"6","author":"Sharma","year":"2000","journal-title":"Curr Opin Pulm Med"},{"issue":"6","key":"10.1016\/j.chest.2026.05.032_bib5","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.4103\/1319-2442.275471","article-title":"Tubulointerstitial nephritis due to sarcoidosis: clinical, laboratory, and histological features and outcome in a cohort of 24 patients","volume":"30","author":"Zammouri","year":"2019","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"10.1016\/j.chest.2026.05.032_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2024.103207","article-title":"Kidney manifestations of sarcoidosis","volume":"149","author":"Bonella","year":"2024","journal-title":"J Autoimmun"},{"issue":"6","key":"10.1016\/j.chest.2026.05.032_bib7","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1172\/JCI101084","article-title":"Blood chemical changes in Boeck\u2019s sarcoid with particular reference to protein, calcium and phosphate value","volume":"18","author":"Harrell","year":"1939","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1016\/j.chest.2026.05.032_bib8","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1172\/JCI111147","article-title":"Metabolism of 25-hydroxyvitamin D3 by cultured pulmonary alveolar macrophages in sarcoidosis","volume":"72","author":"Adams","year":"1983","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1016\/j.chest.2026.05.032_bib9","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1210\/jcem-60-5-960","article-title":"Isolation and structural identification of 1,25-dihydroxyvitamin D3 produced by cultured alveolar macrophages in sarcoidosis","volume":"60","author":"Adams","year":"1985","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.chest.2026.05.032_bib10","doi-asserted-by":"crossref","first-page":"59","DOI":"10.7326\/0003-4819-100-1-59","article-title":"Vitamin D conversion by sarcoid lymph node homogenate","volume":"100","author":"Mason","year":"1984","journal-title":"Ann Intern Med"},{"issue":"9","key":"10.1016\/j.chest.2026.05.032_bib11","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0002-9343(01)00724-0","article-title":"Correlation between 25-hydroxyvitamin D3 1 alpha-hydroxylase gene expression in alveolar macrophages and the activity of sarcoidosis","volume":"110","author":"Inui","year":"2001","journal-title":"Am J Med"},{"issue":"7","key":"10.1016\/j.chest.2026.05.032_bib12","first-page":"2222","article-title":"gamma-Interferon-induced resistance to 1,25-(OH)2 D3 in human monocytes and macrophages: a mechanism for the hypercalcemia of various granulomatoses","volume":"82","author":"Dusso","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.chest.2026.05.032_bib13","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12929-019-0537-6","article-title":"Host-microbe interactions in the pathogenesis and clinical course of sarcoidosis","volume":"26","author":"Ianoka","year":"2019","journal-title":"J Biomed Sci"},{"issue":"11","key":"10.1016\/j.chest.2026.05.032_bib14","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1164\/rccm.201507-1499OC","article-title":"IFN-\u03b3-producing T-helper 17.1 cells are increased in sarcoidosis and are more prevalent than T-helper type 1 cells","volume":"193","author":"Ramstein","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"10.1016\/j.chest.2026.05.032_bib15","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1002\/jbmr.2262","article-title":"Calcium and vitamin D in sarcoidosis: Is supplementation safe?","volume":"29","author":"Kamphuis","year":"2014","journal-title":"J Bone Miner Res"},{"issue":"11","key":"10.1016\/j.chest.2026.05.032_bib16","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.disamonth.2009.05.002","article-title":"Sarcoidosis: extrathoracic manifestation","volume":"55","author":"Holmes","year":"2009","journal-title":"Dis Mon"},{"issue":"7","key":"10.1016\/j.chest.2026.05.032_bib17","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.4103\/jfmpc.jfmpc_203_25","article-title":"A curious case of hypercalcemic crisis in sarcoidosis: the missing link beyond 1,25(OH2)D","volume":"14","author":"Qadir","year":"2025","journal-title":"J Family Med Prim Care"},{"issue":"10","key":"10.1016\/j.chest.2026.05.032_bib18","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1007\/s00198-017-4115-z","article-title":"Use of systemic glucocorticoids and the risk of major osteoporotic fracture in patients with sarcoidosis","volume":"28","author":"Oshagbemi","year":"2017","journal-title":"Osteoporos Int"},{"issue":"12","key":"10.1016\/j.chest.2026.05.032_bib19","first-page":"2088","article-title":"American College of Rheumatology guideline for prevention and treatment of glucocorticoid-induced osteoporosis","volume":"75","author":"Humphrey","year":"2023","journal-title":"Arthritis Rheumatol. 2022."},{"issue":"1","key":"10.1016\/j.chest.2026.05.032_bib20","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1210\/jc.2010-2704","article-title":"The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know","volume":"96","author":"Ross","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"15","key":"10.1016\/j.chest.2026.05.032_bib21","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1001\/jama.2018.3185","article-title":"Vitamin D, calcium, or combined supplementation for the primary prevention of fractures in community-dwelling adults: US Preventive Services Task Force Recommendation Statement","volume":"319","author":"Grossman","year":"2018","journal-title":"JAMA"},{"issue":"15","key":"10.1016\/j.chest.2026.05.032_bib22","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1001\/jama.2017.21640","article-title":"Vitamin D, calcium, or combined supplementation for the primary prevention of fractures in community-dwelling adults: evidence report and systematic review for the US Preventive Services Task Force","volume":"319","author":"Kahwati","year":"2018","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.chest.2026.05.032_bib23","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1056\/NEJMoa2202106","article-title":"Supplemental vitamin D and incident fractures in midlife and older adults","volume":"387","author":"LeBoff","year":"2022","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.chest.2026.05.032_bib24","first-page":"29","article-title":"Bone loss in untreated long standing sarcoidosis","volume":"8","author":"Montemurro","year":"1991","journal-title":"Sarcoidosis"},{"issue":"6","key":"10.1016\/j.chest.2026.05.032_bib25","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.04079-2020","article-title":"ERS clinical practice guidelines on treatment of sarcoidosis","volume":"58","author":"Baughman","year":"2021","journal-title":"Eur Resp J"},{"issue":"1","key":"10.1016\/j.chest.2026.05.032_bib26","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1136\/thoraxjnl-2019-214348","article-title":"BTS clinical statement on pulmonary sarcoidosis","volume":"76","author":"Thillai","year":"2021","journal-title":"Thorax"},{"issue":"5","key":"10.1016\/j.chest.2026.05.032_bib27","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1097\/MCP.0000000000001204","article-title":"Evolving management of sarcoidosis in the real world","volume":"31","author":"Culver","year":"2025","journal-title":"Curr Opin Pulm Med"},{"issue":"4","key":"10.1016\/j.chest.2026.05.032_bib28","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.chest.2024.10.040","article-title":"Sarcoidosis treatment patterns in the United States: 2016 to 2022","volume":"167","author":"Sangani","year":"2025","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.chest.2026.05.032_bib29","first-page":"123","article-title":"Outcome of pulmonary sarcoidosis: a population-based study 1976 to 2013","volume":"35","author":"Ungprasert","year":"2018","journal-title":"Sarcoidosis Vasc Diff Lung Dis"},{"issue":"4","key":"10.1016\/j.chest.2026.05.032_bib30","article-title":"Critical characteristics of sarcoidosis in Asian population: a 14-years single study center retrospective cohort study from Thailand","volume":"37","author":"Tripipitsiriwat","year":"2020","journal-title":"Sarcoidosis Vasc Diff Lung Dis"},{"key":"10.1016\/j.chest.2026.05.032_bib31","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ejim.2022.11.020","article-title":"Systemic treatment in sarcoidosis: Experience over two decades","volume":"108","author":"Fernandez-Ramon","year":"2023","journal-title":"Eur J Intern Med"},{"issue":"6","key":"10.1016\/j.chest.2026.05.032_bib32","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1007\/s00198-017-3962-y","article-title":"Risk of fragility fracture among patients with sarcoidosis: a population-based study 1976-2013","volume":"28","author":"Ungprasert","year":"2017","journal-title":"Osteoporos Int"},{"issue":"4","key":"10.1016\/j.chest.2026.05.032_bib33","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/00002281-200307000-00013","article-title":"Mechanisms of glucocorticoid-induced osteoporosis","volume":"15","author":"Canalis","year":"2003","journal-title":"Curr Opin Rheumatol"},{"issue":"4","key":"10.1016\/j.chest.2026.05.032_bib34","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S2213-2600(25)00338-8","article-title":"A paradigm shift in corticosteroid therapy for sarcoidosis: a World Association of Sarcoidosis and Other Granulomatous Disorders position paper, endorsed by the Americas Association of Sarcoidosis and Other Granulomatous Disorders","volume":"14","author":"Well","year":"2025","journal-title":"Lancet Respir Med"},{"issue":"3","key":"10.1016\/j.chest.2026.05.032_bib35","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1056\/NEJMoa2501443","article-title":"First line treatment of pulmonary sarcoidosis with prednisone or methotrexate","volume":"393","author":"Kahlmann","year":"2025","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.chest.2026.05.032_bib36","first-page":"113","article-title":"Calcium and vitamin D metabolism in sarcoidosis, Sarcoidosis Vasc Diff Lung","volume":"30","author":"Baughman","year":"2013","journal-title":"Dis"},{"issue":"3","key":"10.1016\/j.chest.2026.05.032_bib37","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.amjms.2016.05.027","article-title":"Vitamin D supplementation: not so simple in sarcoidosis","volume":"352","author":"Sodhi","year":"2016","journal-title":"Am J Med Sci"},{"issue":"1","key":"10.1016\/j.chest.2026.05.032_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00000441-200301000-00001","article-title":"Glucocorticoid induced osteoporosis in patients with sarcoidosis","volume":"325","author":"Adler","year":"2003","journal-title":"Am J Med Sci"},{"issue":"10","key":"10.1016\/j.chest.2026.05.032_bib39","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-003562","article-title":"Randomised control trial of vitamin D supplementation in sarcoidosis","volume":"3","author":"Bolland","year":"2013","journal-title":"BMJ Open"},{"issue":"2","key":"10.1016\/j.chest.2026.05.032_bib40","article-title":"Response to corticosteroids and alternative therapies in sarcoidosis-related hypercalcemia: a guideline-lacking retrospective analysis","volume":"42","author":"Robinson","year":"2025","journal-title":"Sarcoidosis Vasc Diff Lung Dis"},{"issue":"16","key":"10.1016\/j.chest.2026.05.032_bib41","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1001\/jama.2022.18331","article-title":"Hypercalcemia: a review","volume":"328","author":"Walker","year":"2022","journal-title":"JAMA"},{"issue":"21","key":"10.1016\/j.chest.2026.05.032_bib42","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1056\/NEJMcp2307353","article-title":"Postmenopausal osteoporosis","volume":"389","author":"Walker","year":"2023","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.chest.2026.05.032_bib43","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00198-007-0543-5","article-title":"FRAX and the assessment of fracture probability in men and women from the UK","volume":"19","author":"Kanis","year":"2008","journal-title":"Osteoporos Int"},{"issue":"10","key":"10.1016\/j.chest.2026.05.032_bib44","article-title":"Bisphosphonates for steroid induced osteoporosis","volume":"10","author":"Allen","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"10.1016\/j.chest.2026.05.032_bib45","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1056\/NEJMoa053569","article-title":"Alendronate or alfacalcidol in glucocorticoid-induced osteoporosis","volume":"355","author":"de Nijs","year":"2006","journal-title":"N Engl J Med"},{"issue":"9671","key":"10.1016\/j.chest.2026.05.032_bib46","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/S0140-6736(09)60250-6","article-title":"Zoledronic acid and risedronate in prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised-controlled trial","volume":"373","author":"Reid","year":"2009","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.chest.2026.05.032_bib47","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2165\/00003088-199936050-00002","article-title":"Pharmacokinetics of alendronate","volume":"36","author":"Porras","year":"1999","journal-title":"Clin Pharmacokinet"},{"issue":"6","key":"10.1016\/j.chest.2026.05.032_bib48","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/MED.0000000000000501","article-title":"Rare adverse effects of bisphosphonate therapy","volume":"26","author":"Ilyas","year":"2019","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"8","key":"10.1016\/j.chest.2026.05.032_bib49","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJMoa0809493","article-title":"Denosumab for prevention of fracture in postmenopausal women with osteoporosis","volume":"361","author":"Cummings","year":"2009","journal-title":"N Engl J Med"},{"issue":"20","key":"10.1016\/j.chest.2026.05.032_bib50","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1056\/NEJMoa071408","article-title":"Teriparatide or alendronate in glucocorticoid-induced osteoporosis","volume":"357","author":"Saag","year":"2007","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.chest.2026.05.032_bib51","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1002\/art.24879","article-title":"Effect of teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: thirty-six-month results of a randomized double-blind, controlled trial","volume":"60","author":"Saag","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.chest.2026.05.032_bib52","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1001\/jama.2016.11136","article-title":"Effect of abaloparatide vs placebo on new vertebral fractures in postmenopausal women with osteoporosis: a randomized clinical trial","volume":"316","author":"Miller","year":"2016","journal-title":"JAMA"},{"issue":"19","key":"10.1016\/j.chest.2026.05.032_bib53","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","article-title":"Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis","volume":"344","author":"Neer","year":"2001","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.chest.2026.05.032_bib54","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jbspin.2015.11.007","article-title":"Teriparatide for osteoporosis in patients with sarcoidosis: report on risk-benefit ratio in four cases","volume":"83","author":"Challal","year":"2016","journal-title":"Joint Bone Spine"},{"issue":"9","key":"10.1016\/j.chest.2026.05.032_bib55","article-title":"Teriparatide and osteosarcoma risk: history, science, elimination of boxed warning, and other label updates","volume":"6","author":"Krege","year":"2022","journal-title":"JMBR Plus"},{"issue":"16","key":"10.1016\/j.chest.2026.05.032_bib56","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa1607948","article-title":"Romosozumab treatment in postmenopausal women with osteoporosis","volume":"375","author":"Cosman","year":"2016","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.chest.2026.05.032_bib57","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1056\/NEJMra2314150","article-title":"Micronutrients \u2014 assessment, requirements, deficiencies, and interventions","volume":"392","author":"Allen","year":"2025","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.chest.2026.05.032_bib58","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3390\/nu17020277","article-title":"Vitamin D: evidence-based health benefits and recommendations for population guidelines","volume":"17","author":"Grant","year":"2025","journal-title":"Nutrients"}],"container-title":["CHEST"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369226007671?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369226007671?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:47:57Z","timestamp":1789519677000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369226007671"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":58,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0012369226007671"],"URL":"https:\/\/doi.org\/10.1016\/j.chest.2026.05.032","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Calcium and Vitamin D Supplements in Patients With Sarcoidosis","name":"articletitle","label":"Article Title"},{"value":"CHEST","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chest.2026.05.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American College of Chest Physicians. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}